Package | ans.fhir.fr.eclaire |
Type | CodeSystem |
Id | eclaire-study-phase-source-code-system |
FHIR Version | R4 |
Source | https://interop.esante.gouv.fr/ig/fhir/eclaire/https://interop.esante.gouv.fr/ig/fhir/eclaire/0.3.0/CodeSystem-eclaire-study-phase-source-code-system.html |
URL | https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system |
Version | 0.3.0 |
Status | draft |
Date | 2024-02-26T13:32:37+00:00 |
Name | EclaireStudyPhaseSourceCS |
Title | Définition des phase de l'essai utilisés dans la base de données ECLAIRE |
Realm | fr |
Authority | national |
Description | Définition des phases de l'essai utilisées dans la base de données ECLAIRE |
Content | complete |
ValueSet | |
eclaire-study-phase-source-vs | Value Set de la phase de l'essai tel que définie dans la base ECLAIRE |
No resources found
Note: links and images are rebased to the (stated) source
This case-sensitive code system https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system
defines the following codes:
{ "resourceType": "CodeSystem", "id": "eclaire-study-phase-source-code-system", "text": { "status": "generated", "div": "<!-- snip (see above) -->" }, "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system", "version": "0.3.0", "name": "EclaireStudyPhaseSourceCS", "title": "Définition des phase de l'essai utilisés dans la base de données ECLAIRE", "status": "draft", "date": "2024-02-26T13:32:37+00:00", "publisher": "ANS", "contact": [ { "name": "ANS", "telecom": [ { "system": "url", "value": "https://esante.gouv.fr" } ] } ], "description": "Définition des phases de l'essai utilisées dans la base de données ECLAIRE", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "FR", "display": "FRANCE" } ] } ], "caseSensitive": true, "content": "complete", "count": 12, "concept": [ { "code": "jarde-early", "display": "Jardé phase précoce" }, { "code": "phase-I-first-admin", "display": "Human Pharmacology (Phase I) - First administration to humans" }, { "code": "phase-I-bioequivalence", "display": "Human Pharmacology (Phase I) - Bioequivalence Study" }, { "code": "phase-I-other", "display": "Human Pharmacology (Phase I) - Other" }, { "code": "phase-I-II-first-admin", "display": "Phase I and Phase II (Integrated) - First administration to humans" }, { "code": "phase-I-II-first-bioequivalence", "display": "Phase I and Phase II (Integrated) - Bioequivalence Study" }, { "code": "phase-I-II-other", "display": "Phase I and Phase II (Integrated) - Other" }, { "code": "phase-II", "display": "Therapeutic exploratory (Phase II)" }, { "code": "phase-II-III", "display": "Phase II and Phase III (Integrated)" }, { "code": "phase-III", "display": "Therapeutic confirmatory (Phase III)" }, { "code": "phase-IV", "display": "Therapeutic use (Phase IV)" }, { "code": "phase-III-IV", "display": "Phase III and phase IV (Integrated)" } ] }